Skip to main content
. 2018 Dec 18;19(12):4111. doi: 10.3390/ijms19124111
ADAM a disintegrin and metalloproteinase
AFP α-fetoprotein
BCLC Barcelona Clinic Liver Cancer
EGFR epidermal growth factor receptor
EMT epithelial to mesenchymal transition
ERK extracellular-signal regulated kinase
FLT3 FMS-like tyrosine kinase
Gas6 growth arrest specific gene 6
GVHD graft versus host disease
HB-EGF heparin-binding EGF-like growth factor
HBV hepatitis B virus
HCC hepatocellular carcinoma
HCV hepatitis C virus
HER human epidermal growth factor receptor
HIF hypoxia- inducible factor
HSC hepatic stellate cell
I/R ischemia/reperfusion
ICD intracellular domain
IFN interferon
IFNAR interferon α/β receptor
IL interleukin
JAK/STAT Janus kinase/signal transducers and activators of transcription
JNK c-Jun-N-terminal kinase
KO knock-out
MAPK mitogen activated protein kinase
MAPKi inhibition of the MAPK pathway
MCP monocyte chemotactic protein
MMP matrix metalloprotease
NAFLD non-alcoholic fatty liver disease
NASH non-alcoholic steatohepatitis
NF-κB nuclear factor κ-light-chain-enhancer of activated B cells
NK natural killer
PDGFR platelet-derived growth factor receptor
PI3K phosphoinositide 3-kinase
PKC protein kinase C
ProS Protein S
RTK receptor tyrosine kinase
sAxl soluble Axl
sIL-6R soluble interleukin-6 receptor
SOCS suppressors of cytokine signaling
TAM Tyro3, Axl, Mer
TGF transforming growth factor
TKi tyrosine kinase inhibitors
TLR Toll-like receptor
TME tumor microenvironment
TNF tumor necrosis factor
VEGFR vascular endothelial growth factor receptor
YAP Yes-associated protein